The UK government's vaccine advisory group (JCVI) has recommended not vaccinating anyone younger than 30 years old with AstraZeneca. This decision is associated with cases of rare blood clots after vaccination with the drug. This was reported by BBC.
The review by the Medicines and Healthcare products Regulatory Agency (MHRA) found that by the end of March 79 people had suffered rare blood clots after vaccination - 19 of whom had died.
The review prompted the UK government's vaccine advisory group to recommend that people aged 18 to 29 be offered an alternative vaccine where available.
The regulator said this was not proof the jab had caused the clots.
Meanwhile, the European Medicines Agency (EMA) defined the possibility of the link between the AstraZeneca vaccine and rare cases of blood clots after the vaccination as the EMA reported.
“EMA’s safety committee (PRAC) has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca),” the message said.
It is stated that blood clots might appear two weeks after the vaccination.